Go Pro

Adagio Medical (ADGM) Competitors

Adagio Medical logo
$0.50 +0.04 (+7.99%)
Closing price 04:00 PM Eastern
Extended Trading
$0.50 0.00 (-0.80%)
As of 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADGM vs. COCH, SRTS, MDAI, POCI, and BDMD

Should you buy Adagio Medical stock or one of its competitors? Adagio Medical's main competitors and comparable companies include Envoy Medical (COCH), Sensus Healthcare (SRTS), Spectral AI (MDAI), Precision Optics (POCI), and Baird Medical Investment (BDMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Adagio Medical compare to Envoy Medical?

Envoy Medical (NASDAQ:COCH) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

Envoy Medical has higher earnings, but lower revenue than Adagio Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$240K228.39-$23.76M-$0.76N/A
Adagio Medical$600K18.47-$25.08M-$1.48N/A

Adagio Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-11,304.83% N/A -144.13%
Adagio Medical N/A -661.85%-73.35%

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by insiders. Comparatively, 7.8% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Envoy Medical has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market.

In the previous week, Adagio Medical had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Adagio Medical and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.89 beat Adagio Medical's score of 1.87 indicating that Envoy Medical is being referred to more favorably in the media.

Company Overall Sentiment
Envoy Medical Very Positive
Adagio Medical Very Positive

Envoy Medical currently has a consensus target price of $2.00, indicating a potential upside of 181.65%. Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 601.40%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Envoy Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Adagio Medical beats Envoy Medical on 10 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Sensus Healthcare?

Adagio Medical (NASDAQ:ADGM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

Sensus Healthcare has higher revenue and earnings than Adagio Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K18.47-$25.08M-$1.48N/A
Sensus Healthcare$27.48M1.84-$7.72M-$0.94N/A

Adagio Medical has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -661.85% -73.35%
Sensus Healthcare -88.45%-21.57%-19.20%

In the previous week, Sensus Healthcare had 1 more articles in the media than Adagio Medical. MarketBeat recorded 3 mentions for Sensus Healthcare and 2 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.87 beat Sensus Healthcare's score of 0.88 indicating that Adagio Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Sensus Healthcare
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Adagio Medical currently has a consensus price target of $3.50, indicating a potential upside of 601.40%. Sensus Healthcare has a consensus price target of $5.83, indicating a potential upside of 90.01%. Given Adagio Medical's higher possible upside, equities research analysts clearly believe Adagio Medical is more favorable than Sensus Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Sensus Healthcare
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Adagio Medical has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, indicating that its share price is 13% more volatile than the broader market.

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Sensus Healthcare beats Adagio Medical on 10 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Spectral AI?

Adagio Medical (NASDAQ:ADGM) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Adagio Medical has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Spectral AI has higher revenue and earnings than Adagio Medical. Spectral AI is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio Medical$600K18.47-$25.08M-$1.48N/A
Spectral AI$19.65M2.54-$7.57M-$0.35N/A

Adagio Medical presently has a consensus target price of $3.50, suggesting a potential upside of 601.40%. Spectral AI has a consensus target price of $4.00, suggesting a potential upside of 158.06%. Given Adagio Medical's higher possible upside, research analysts plainly believe Adagio Medical is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A -661.85% -73.35%
Spectral AI -69.27%N/A -78.56%

In the previous week, Spectral AI had 2 more articles in the media than Adagio Medical. MarketBeat recorded 4 mentions for Spectral AI and 2 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.87 beat Spectral AI's score of 0.82 indicating that Adagio Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Spectral AI
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Spectral AI beats Adagio Medical on 10 of the 17 factors compared between the two stocks.

How does Adagio Medical compare to Precision Optics?

Precision Optics (NASDAQ:POCI) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, Precision Optics had 3 more articles in the media than Adagio Medical. MarketBeat recorded 5 mentions for Precision Optics and 2 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.87 beat Precision Optics' score of 0.72 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by insiders. Comparatively, 7.8% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
Adagio Medical N/A -661.85%-73.35%

Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market.

Precision Optics has higher revenue and earnings than Adagio Medical. Precision Optics is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.39-$5.78M-$0.63N/A
Adagio Medical$600K18.47-$25.08M-$1.48N/A

Adagio Medical has a consensus target price of $3.50, suggesting a potential upside of 601.40%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Precision Optics and Adagio Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Adagio Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

19.8% of Baird Medical Investment shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Comparatively, 7.8% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Adagio Medical has a consensus price target of $3.50, suggesting a potential upside of 601.40%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Baird Medical Investment had 4 more articles in the media than Adagio Medical. MarketBeat recorded 6 mentions for Baird Medical Investment and 2 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 1.87 beat Baird Medical Investment's score of 0.67 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baird Medical Investment
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Baird Medical Investment has higher revenue and earnings than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$22.54M1.99N/AN/AN/A
Adagio Medical$600K18.47-$25.08M-$1.48N/A

Baird Medical Investment has a beta of -1.15, suggesting that its share price is 215% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market.

Baird Medical Investment's return on equity of 0.00% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Adagio Medical N/A -661.85%-73.35%

Summary

Adagio Medical beats Baird Medical Investment on 7 of the 12 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$11.08M$5.49B$7.19B$14.92B
Dividend YieldN/A1.79%2.57%11.71%
P/E Ratio-0.3425.26274.0925.35
Price / Sales18.4768.32697.83112.39
Price / CashN/A32.7877.7151.48
Price / Book0.855.9610.376.25
Net Income-$25.08M$151.55M$3.49B$358.55M
7 Day Performance-17.52%-1.60%-1.78%-2.07%
1 Month Performance-27.91%-4.12%-1.48%-4.80%
1 Year Performance-69.29%8.63%18.20%5.44%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
3.1791 of 5 stars
$0.50
+8.0%
$3.50
+601.4%
-72.5%$11.08M$600KN/A87
COCH
Envoy Medical
2.6866 of 5 stars
$0.71
-0.7%
$2.00
+183.3%
-46.6%$54.50M$240KN/A34
SRTS
Sensus Healthcare
3.4588 of 5 stars
$3.15
-0.5%
$5.83
+85.5%
-2.2%$51.77M$27.48MN/A40
MDAI
Spectral AI
1.9832 of 5 stars
$1.58
-1.8%
$4.00
+153.0%
-20.1%$50.89M$19.65MN/A83
POCI
Precision Optics
0.8299 of 5 stars
$4.37
-0.5%
N/A-4.1%$47.83M$28.94MN/A80

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners